Atea Pharmaceuticals (AVIR) Competitor Comparison
We are evaluating the key criteria listed to compare Atea Pharmaceuticals (AVIR) against its competitors in the Biotechnology industry.
Market Capitalization
186 / 368Gross Profits
228 / 278Total Revenue
0 / 300EBITDA
239 / 337Free Cashflow
152 / 352Quick Ratio
10 / 357Earnings per Share
214 / 359Dividend yield
0 / 6Total Cash
49 / 358Performance 3 years
189 / 368Performance 5 years
256 / 368Performance 10 years
225 / 368Linearity 3 years
142 / 368Linearity 5 years
258 / 368Linearity 10 years
197 / 367Total Rank
19 / 368Dividend Rank
366 / 368Valuation Rank
10 / 368Piotroski Rank
31 / 368Muliplier Rank
2 / 368Market Capitalization - AVIR ranking 186 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.